Xianjie Chen

Xianjie Chen

Auto-generated profile, based on publicly available information

Xianjie Chen

Research Centre of Basic Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, PR China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
XCXianjie Chen
Xianjie Chen
ZXZhenyuan Xu
Zhenyuan Xu
MLMeng Lu
Meng Lu
WDWenjun Ding
Wenjun Ding
JZJun Zhong
Jun Zhong
HLHui Li
Hui Li
The abnormal immune response mediated by malignant melanoma is related to PD1. Paeonol has pharmacological antitumor activity. Previous studies have indicated that paeonol induces tumor cell apoptosis, but its underlying mechanism in tumor immunity remains unknown. In this study, malignant melanoma was established in normal and thymectomized mice to determine the important role of the thymus in the antitumor effects of paeonol. Paeonol-treated thymocytes were cocultured with melanoma cell spheres to further evaluate the regulatory role of thymocytes in tumor immune dysfunction. Studies have shown that PD1 may be targeted by miR-139-5p. Our results revealed that tumor-induced thymic atrophy was significantly accompanied by high PD1 expression and low miR-139-5p expression. Interestingly, paeonol significantly reversed thymic atrophy and largely protected thymocytes against low PD1 expression and high miR-139-5p expression. Dual-luciferase assays indicated that miR-139-5p interacted with the 3' untranslated region (3'-UTR) of PD1. These results showed that paeonol alleviates PD1-mediated antitumor immunity by reducing miR-139-5p expression and demonstrated a novel mechanism for melanoma immunotherapy.

5 November 2025 in Journal of Ginseng Research
Verified
Journal Article
Open access
LTLulu Tang
Lulu Tang
XCXianjie Chen
Xianjie Chen
KCKeyue Chen
Keyue Chen
XZXinlei Zheng
Xinlei Zheng
MYMin Ye
Min Ye
XLXiaoyi Liu
Xiaoyi Liu
Skin photoaging is a chronic inflammatory state induced by ultraviolet (UV) radiation. Ferroptosis has recently emerged as a critical mechanism implicated in the pathogenesis of photoaging. Ginsenosides, active compounds in ginseng, hold potential for treating skin photoaging, but their molecular mechanisms in regulating ferroptosis remain unclear. We utilized single-cell RNA sequencing (scRNA-seq) to analyze murine skin after UVB irradiation, focusing on keratinocyte subpopulations and ferroptosis-related genes. Molecular docking assessed ginsenoside binding to ferroptosis regulators. Embryotoxicity of ginsenosides was evaluated using zebrafish embryos. Ferroptosis gene expression in UVB-exposed keratinocytes with or without ginsenoside treatment was analyzed by Western blot and RT-qPCR. scRNA-seq revealed a significant increase in keratinocyte numbers and ferroptosis signals following UVB irradiation. We observed that UVB exposure reduced SLC7A11 and GPX4 expression while increasing HMGB1 in keratinocytes. Molecular docking experiments further indicated that ginsenosides C-K and C-Mc can target ferroptosis-related proteins, and are non-toxic in zebrafish embryos. Treatment with ginsenosides effectively attenuated skin photoaging by modulating the SLC7A11/GPX4 axis and suppressing HMGB1 expression, thereby reducing UVB-induced reactive oxygen species levels and restoring keratinocyte viability. Additionally, we also identified three differentiation trajectories of keratinocytes and found that bone marrow-derived cell Gas6 signaling may influence ferroptosis via the Axl/Tyro3 pathway. Our findings suggest that ginsenosides may represent promising therapeutic candidates for alleviating UVB-induced skin photoaging via modulation of the ferroptosis-associated SLC7A11/GPX4 axis and HMGB1 expression, providing novel mechanistic insights and therapeutic strategies against skin photoaging.